Artificial intelligence (AI) applied in the biopharmaceutical sector involves the utilization of diverse AI techniques to analyze intricate biological data and enhance different aspects of drug discovery, development, and delivery within the pharmaceutical domain. This application of AI holds significant potential for transforming drug discovery, development, and delivery processes by expediting timelines, cutting costs, and enhancing the efficiency and efficacy of treatments.
The primary categories of offerings in artificial intelligence (AI) within the biopharmaceutical sector encompass hardware, software, and services. Hardware pertains to the tangible components of a computer system, including devices such as memory, disk drives, controllers, and specialized software such as database management systems. These offerings span various deployment models, encompassing both cloud-based and on-premises solutions. The technologies employed include machine learning, natural language processing, and deep learning, with applications spanning business processes, supply chains, drug discovery, medical imaging and diagnostics, and precision medicine. The end users of these AI solutions are diverse, ranging from manufacturers and contract research organizations to academic and government research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The artificial intelligence (AI) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in biopharmaceuticals market statistics, including artificial intelligence (AI) in biopharmaceuticals industry global market size, regional shares, competitors with an artificial intelligence (AI) in biopharmaceuticals market share, detailed artificial intelligence (AI) in biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in biopharmaceuticals industry. This artificial intelligence (AI) in biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (AI) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $1.59 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 32.2%. The growth in the historic period can be attributed to advancements in computational power, biomedical data explosion, precision medicine paradigm, regulatory support and guidance.
The artificial intelligence (AI) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $6.58 billion in 2029 at a compound annual growth rate (CAGR) of 33.0%. The growth in the forecast period can be attributed to advancements in computational biology, integration of multi-modal data, convergence of ai and life sciences, regulatory support and frameworks, ethical and fair ai principles. Major trends in the forecast period include integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.
The forecast of 33.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. drug discovery efforts by driving up costs of artificial intelligence-powered drug design platforms sourced from the UK and Israel, exacerbating research and development expenses and increasing biopharmaceutical innovation burdens while delaying novel therapy development. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of chronic diseases is projected to drive the growth of the artificial intelligence (AI) in biopharmaceuticals market in the future. Chronic diseases are long-term conditions that typically progress slowly and can persist for years or even a lifetime. Factors contributing to these diseases include lifestyle choices, an aging population, genetic predispositions, and environmental influences. AI is increasingly utilized in biopharmaceuticals for managing chronic diseases as it can analyze vast amounts of diverse data, identify patterns, and personalize treatment strategies. For example, in November 2023, the Department of Health and Human Services, a US government agency, reported an 11 percent increase in newly documented chronic hepatitis B cases in 2022 compared to 2021. Consequently, the rising prevalence of chronic diseases is driving growth in the AI biopharmaceuticals market.
Key players in artificial intelligence (AI) in biopharmaceuticals are focused on developing innovative advancements such as target and lead identification suite AI-powered solutions to expedite drug discovery and enable precision medicine, thereby transforming life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For example, in May 2023, Google LLC, a US-based provider of cloud computing services, introduced two new AI-powered tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding the structure of proteins, a fundamental aspect of drug development. Additionally, the suite facilitates the ingestion, storage, analysis, and sharing of large volumes of genomic data, crucial for precision medicine initiatives. Furthermore, these tools streamline the drug discovery process, reduce costs, and expedite the introduction of new treatments to market. By offering efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and enhance patient outcomes.
In February 2023, ZS Associates, a management consulting and technology firm based in the United States, successfully acquired Trials.ai Inc. for an undisclosed sum. This strategic acquisition is geared towards elevating design processes within the pharmaceutical industry by harnessing artificial intelligence (AI). The goal is to optimize operational speed, enhance participant experiences, and accelerate the delivery of pharmaceutical therapies to the market. Trials.ai Inc., headquartered in the US, specializes in revolutionizing clinical trials through the application of artificial intelligence (AI) and machine learning (ML) technologies.
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrodinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial intelligence (ai) in biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence (ai) in biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence (ai) in biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Offering: Hardware; Software; Services
- 2) By Deployment: Cloud; On-Premises
- 3) By Technology: Machine Learning; Natural Language Processing; Deep Learning; Other Technologies
- 4) By Application: Business Process And Supply Chain; Drug Discovery; Medical Imaging And Diagnostics; Precision Medicine
- 5) By End-Users: Manufacturers; Contract Research Organizations; Academic And Government Research Institutes
- Subsegments:
- 1) By Hardware: High-Performance Computing Systems; AI-Enabled Laboratory Equipment; Data Storage Solutions
- 2) By Software: Drug Discovery Platforms; Clinical Trial Management Software; Predictive Analytics Tools; Natural Language Processing Solutions
- 3) By Services: Consulting Services; Implementation And Integration Services; Data Management And Analytics Services; Training And Support Services
- Companies Mentioned: Apple Inc.; Google LLC; Microsoft Corporation; Tencent Holdings Limited; Amazon Web Services Inc.; International Business Machines Corporation; Exscientia Limited; NVIDIA Corporation; Amgen Inc.; DeepMind Technologies Limited; Schrodinger Inc.; XtalPi Inc.; ConcertAI Inc.; Insilico Medicine Inc.; Recursion Pharmaceuticals; BenevolentAI; BioXcel Therapeutics; Atomwise Inc.; BioAge Labs Inc.; GNS Healthcare; Berg Health; Deep 6 AI Inc.; Cloud Pharmaceuticals Inc.; Numerate Inc.; AI Therapeutics; Envisagenics; twoXAR Inc.; Cyclica Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics
3. Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies
4. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Artificial Intelligence (AI) In Biopharmaceuticals Growth Analysis And Strategic Analysis Framework
- 5.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Rate Analysis
- 5.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM)
6. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation
- 6.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hardware
- Software
- Services
- 6.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cloud
- On-Premises
- 6.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Machine Learning
- Natural Language Processing
- Deep Learning
- Other Technologies
- 6.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Business Process And Supply Chain
- Drug Discovery
- Medical Imaging And Diagnostics
- Precision Medicine
- 6.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Manufacturers
- Contract Research Organizations
- Academic And Government Research Institutes
- 6.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- High-Performance Computing Systems
- AI-Enabled Laboratory Equipment
- Data Storage Solutions
- 6.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Discovery Platforms
- Clinical Trial Management Software
- Predictive Analytics Tools
- Natural Language Processing Solutions
- 6.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consulting Services
- Implementation And Integration Services
- Data Management And Analytics Services
- Training And Support Services
7. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis
- 7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market
- 8.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence (AI) In Biopharmaceuticals Market
- 9.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 9.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence (AI) In Biopharmaceuticals Market
- 10.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market
- 11.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 11.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market
- 12.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market
- 13.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market
- 14.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 14.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market
- 15.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 15.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence (AI) In Biopharmaceuticals Market
- 16.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market
- 17.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artificial Intelligence (AI) In Biopharmaceuticals Market
- 18.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market
- 19.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market
- 20.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market
- 21.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 21.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market
- 22.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence (AI) In Biopharmaceuticals Market
- 23.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 23.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence (AI) In Biopharmaceuticals Market
- 24.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 24.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market
- 25.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 25.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence (AI) In Biopharmaceuticals Market
- 26.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 26.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market
- 27.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market
- 28.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 28.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market
- 29.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
- 29.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles
- 30.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape
- 30.2. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles
- 30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Google LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Tencent Holdings Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies
- 31.1. International Business Machines Corporation
- 31.2. Exscientia Limited
- 31.3. NVIDIA Corporation
- 31.4. Amgen Inc.
- 31.5. DeepMind Technologies Limited
- 31.6. Schrodinger Inc.
- 31.7. XtalPi Inc.
- 31.8. ConcertAI Inc.
- 31.9. Insilico Medicine Inc.
- 31.10. Recursion Pharmaceuticals
- 31.11. BenevolentAI
- 31.12. BioXcel Therapeutics
- 31.13. Atomwise Inc.
- 31.14. BioAge Labs Inc.
- 31.15. GNS Healthcare
32. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market
34. Recent Developments In The Artificial Intelligence (AI) In Biopharmaceuticals Market
35. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies
- 35.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
